No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
QNCX Quince Therapeutics
- 1.780
- +0.020+1.14%
Close Dec 20 16:00 ET
- 1.850
- +0.070+3.93%
Post 20:01 ET
78.32MMarket Cap-1.44P/E (TTM)
1.847High1.740Low106.26KVolume1.760Open1.760Pre Close188.03KTurnover0.30%Turnover RatioLossP/E (Static)44.00MShares2.45052wk High1.74P/B62.90MFloat Cap0.51252wk Low--Dividend TTM35.34MShs Float121.980Historical High--Div YieldTTM6.08%Amplitude0.512Historical Low1.769Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Brookline Capital Initiates Quince Therapeutics(QNCX.US) With Buy Rating, Announces Target Price $9
Quince Therapeutics Files Mixed Securities Shelf; Shares Rise After Hours
Express News | Quince Therapeutics: Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing
This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Brookline Capital Initiates Coverage On Quince Therapeutics With Buy Rating, Announces Price Target of $9
Quince Therapeutics Analyst Ratings
Heat List
US
Overall
Symbol
Price
% Chg
No Data